Regulating the expression of nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome-related molecules in dental pulp fibroblasts under inflammation

doi:10.12307/2022.810

Abstract

Abstract: BACKGROUND: Nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 inflammasome is an important inflammatory factor for cellular defense against various pathogens, which has been confirmed to be expressed in dental pulp fibroblasts. However, the mechanisms underlying the transcription regulation of NOD-like receptor protein 3 inflammasome in dental pulp fibroblasts under inflammation remains unclear.
OBJECTIVE: To elucidate the mechanisms underlying the transcription regulation of NOD-like receptor protein 3 inflammasome in dental pulp fibroblasts under inflammation.
METHODS: The 4th generation dental pulp fibroblasts were divided into six groups. Group A was cultured normally without any treatment. Group B was simulated with lipopolysaccharide for 6 hours. Group C was treated with a specific inhibitor of Toll-like receptor 4 for 1 hour, and then it was also treated with a mixed solution of Toll-like receptor 4 specific inhibitor and lipopolysaccharide for 6 hours. Group D was treated with a specific inhibitor of myeloid differentiation factor 88 for 1 hour, and then treated with a mixed solution of specific inhibitor of myeloid differentiation factor 88 and lipopolysaccharide for 6 hours. Group E was treated with a specific inhibitor of nuclear factor κB for 1 hour, and then treated with a mixture solution of specific inhibitor of nuclear factor κB and lipopolysaccharide for 6 hours. Group F was treated with a negative control of myeloid differentiation factor 88 specific inhibitor for 1 hour, and then treated with a mixed solution of myeloid differentiation factor 88 specific inhibitor negative control and lipopolysaccharide for 6 hours. Real-time polymerase chain reaction was used to detect the mRNA expression of NOD-like receptor protein 3, Caspase-1 and interleukin 1β. Western bolt was used to detect the expression of NOD-like receptor protein 3 and Caspase-1. And enzyme linked immunosorbent assay was used to detect the release level of interleukin 1β.
RESULTS AND CONCLUSION: Compared with group A, the mRNA expression of NOD-like receptor protein 3, Caspase-1 and interleukin 1β was increased in group B (P < 0.05), while compared with group B, the mRNA expression of NOD-like receptor protein 3 and interleukin 1β was decreased in groups C-E (P < 0.05), and the mRNA expression of Caspase-1 was also decreased in group C (P < 0.05). Compared with group A, the protein expression of NOD-like receptor protein 3 and Caspase-1 was increased in group B (P < 0.05), while compared with group B, the protein expression of NOD-like receptor protein 3 was decreased in groups C-E (P < 0.05), and the protein expression of Caspase-1 was also decreased in group C (P < 0.05). Compared with group A, the level of interleukin 1β was increased in group B (P < 0.05), while compared with group B, the levels of interleukin 1β were decreased in groups C-E (P < 0.05). All these findings indicate that lipopolysaccharide upregulates the expression of NOD-like receptor protein 3 and interleukin 1β in dental pulp fibroblasts through the Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway.

Key words: dental pulp fibroblasts, innate immunity, nucleotide-binding oligomerization domain-like receptor 4, nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome, signaling pathway, interleukin 1β, nuclear factor κB

CLC Number:

Zhang Ansheng, Zhang Haiou, Ni Longxing. Regulating the expression of nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome-related molecules in dental pulp fibroblasts under inflammation[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(26): 4107-4112.

Figures/Tables 4

References

[1] HAHN CL, LIEWEHR FR. Relationships between Caries Bacteria, Host Responses, and Clinical Signs and Symptoms of Pulpitis. J Endod. 2007; 33(3):213-219.
[2] JONTELL M, OKIJI T, DAHLGREN U, et al. Immune defense mechanisms of the dental pulp. Crit Rev Oral Biol Med. 1998;9(2):179-200.
[3] HOU CW, LAURO ML, GRIMES CL. Redefining the Defensive Line: Critical Components of the Innate Immune System. ACS Infect Dis. 2016;2(11):746-748.
[4] LIU J, CAO X. Cellular and molecular regulation of innate inflammatory responses. Cell Mol Immunol. 2016;13(6):711-721.
[5] HIRAO K, YUMOTO H, TAKAHASHI K, et al.Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. J Dent Res. 2009;88(8):762-767.
[6] TOKUDA M, SAKUTA T, FUSHUKU A, et al.Regulation of interleukin-6 expression in human dental pulp cell cultures stimulated with Prevotella intermedia lipopolysaccharide. J Endod. 2001;27(4):273-277.
[7] NAGAOKA S, TOKUDA M, SAKUTA T, et al. Interleukin-8 gene expression by human dental pulp fibroblast in cultures stimulated with Prevotella intermedialipopolysaccharide. J Endod. 1996;22(1):9-12.
[8] BARKHORDAR RA, GHANI QP, RUSSELL TR, et al. Interleukin-1beta activity and collagen synthesis in human dental pulp fibroblasts. J Endod. 2002;28:157-159.
[9] SCHRODER K, TSCHOPP J. The inflammasomes. Cell. 2010;140:821-832.
[10] SONG Z, LIN Z, HE F, et al. NLRP3 Is Expressed in Human Dental Pulp Cells and Tissues. J Endod. 2012;38:1592-1597.
[11] JIANG W, LV H, WANG H, et al. Activation of the NLRP3/caspase-1 inflammasome in human dental pulp tissue and human dental pulp fibroblasts. Cell Tissue Res. 2015;361(2):541-455.
[12] BAUERNFEIND FG, HORVATH G, STUTZ A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787-791.
[13] 蒋文凯,童忠春,王迪雅,等.NLRP3、Caspase-1炎症体通路在人牙髓成纤维细胞中表达和相关调控因素的初步检测[J].牙体牙髓牙周病学杂志,2013,23(1):1-5.
[14] CASO F, COSTA L, NUCERA V, et al. From autoinflammation to autoimmunity: old and recent findings. Clin Rheumatol. 2018;37(9): 2305-2321.
[15] FUSCO R, SIRACUSA R, GENOVESE T, et al. Focus on the Role of NLRP3 Inflammasome in Diseases. Int J Mol Sci. 2020;21(12):4223.
[16] THEOHARIDES TC. Danger Signals and Inflammation. Clin Ther. 2016; 38(5):996-999.
[17] ELLIOTT EI, SUTTERWALA FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265(1): 35-52.
[18] NOONIN C, THONGBOONKERD V. Exosome-inflammasome crosstalk and their roles in inflammatory responses. Theranostics. 2021;11(9): 4436-4451.
[19] SHEN R, YIN P, YAO H, et al. Punicalin Ameliorates Cell Pyroptosis Induced by LPS/ATP Through Suppression of ROS/NLRP3 Pathway. J Inflamm Res. 2021;14:711-718.
[20] MEZZASOMA L, ANTOGNELLI C, TALESA VN. Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells. Immunol Res. 2016;64(1):303-312.
[21] HAMILTON IR. Ecological basis for dental caries. In: Kuramitsu HK, Ellen RP, editors. Oral bacterial ecology: the molecular basis. Wymondham, UK: Horizon Scientific Press, 2000:219-274.
[22] NARDO DD, BALKA KR, GLORIA YC, et al. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling. J Biol Chem. 2018;293(39):15195-15207.
[23] ZHANG J, MACARTNEY T, PEGGIE M, et al. Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3. Biochem J. 2017;474(13):2235-2248.
[24] FENG H, ZHANG YB, GUI JF, et al. Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses. PLoS Pathog. 2021; 17(1):e1009220.
[25] SCHMITZ F, HEIT A, GUGGEMOOS S, et al. Interferonregulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol. 2007;37:315-327.
[26] FUNAMI K, MATSUMOTO M, OSHIUMI H, et al. Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling. Biochem Soc Trans. 2017;45(4):929-935.
[27] ZHAO XY, HUO RX, YAN XL, et al. IRF3 Negatively Regulates Toll-Like Receptor-Mediated NF-κB Signaling by Targeting TRIF for Degradation in Teleost Fish. Front Immunol. 2018;9:867.
[28] BERTHELOOT D, LATZ E, FRANKLIN BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021; 18(5):1106-1121.
[29] Cui J, Chen Y, Wang HY, et al. Mechanisms and pathways of innate immune activation and regulation in health and cancer. Hum Vaccin Immunother. 2014;10(11):3270-3285.